Daniel J. Brennan - Feb 15, 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP and CFO
Signature
/s/ Susan Thompson, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
Feb 15, 2023
Transactions value $
-$358,617
Form type
4
Date filed
2/16/2023, 06:15 PM
Previous filing
Feb 15, 2023
Next filing
Feb 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $56K +7.57K +2.77% $7.39* 281K Feb 15, 2023 Direct F1
transaction BSX Common Stock Options Exercise $0 +4.15K +1.48% $0.00 285K Feb 15, 2023 Direct F2
transaction BSX Common Stock Tax liability -$57.6K -1.22K -0.43% $47.29 284K Feb 15, 2023 Direct
transaction BSX Common Stock Sale -$357K -7.57K -2.67% $47.14 276K Feb 15, 2023 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Deferred Stock Units Options Exercise $0 -4.15K -100% $0.00* 0 Feb 15, 2023 Common Stock 4.15K Direct F2, F4
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -7.57K -100% $0.00* 0 Feb 15, 2023 Common Stock 7.57K $7.39 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2 Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F3 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.993 to $47.26, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
F5 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal installments beginning on February 28, 2014, the first anniversary of the date of grant.